Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 455
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03986073 | Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus | ||
| NCT06165822 | A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets | ||
| NCT07407803 | Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas | ||
| NCT06146751 | A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus | ||
| NCT05607446 | To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis | ||
| NCT04061109 | Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. | ||
| NCT05745363 | Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer | ||
| NCT02332499 | Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703) | ||
| NCT06569524 | Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) | ||
| NCT07551427 | A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis | ||
| NCT01874873 | A Phase II Study of Anlotinib in MTC Patients | ||
| NCT05375461 | TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail | ||
| NCT07291050 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT05913089 | A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer | ||
| NCT06900920 | A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia | ||
| NCT06825494 | Clinical Studies for the Treatment of Advanced Solid Tumors | ||
| NCT05198505 | Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT07267130 | A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects | ||
| NCT06585059 | Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers | ||
| NCT04523285 | A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics | ||
| NCT04924192 | A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer | ||
| NCT03983928 | Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer | ||
| NCT03991975 | Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma | ||
| NCT06487416 | A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions | ||
| NCT05800106 | A Bioequivalence Study of Sunitinib Malate Capsules. | ||
| NCT06990776 | A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects | ||
| NCT06116240 | A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors | ||
| NCT07266116 | Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients | ||
| NCT05640804 | A Bioequivalence Study of Dasatinib Tablet | ||
| NCT05306847 | Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer | ||
| NCT06561607 | A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer | ||
| NCT03790228 | Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC | ||
| NCT07083739 | A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults | ||
| NCT06122831 | A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) | ||
| NCT02779699 | A Study of AL2846 on Tolerance and Pharmacokinetics | ||
| NCT07172126 | Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets | ||
| NCT02671942 | A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients | ||
| NCT05975645 | A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). | ||
| NCT03460457 | Tolerance and Pharmacokinetics of TQB2450 | ||
| NCT05344729 | Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects | ||
| NCT02029209 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT04853498 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets | ||
| NCT06542614 | Treatment of Moderate to Severe Plaque Psoriasis | ||
| NCT06929195 | Clinical Trial to Evaluate the Tolerance of TQB2210 Injection | ||
| NCT06598956 | To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects | ||
| NCT06451640 | A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps | ||
| NCT03972189 | Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT01846650 | A Bioequivalence Study of Capecitabine Tablets | ||
| NCT04080843 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | ||
| NCT04325776 | A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis |
